Omicron Variant: Tide Labs Resolves False-Negative Problem With COVID-19 Tests
Executive Summary
The US FDA says the company fixed the problem with its coronavirus diagnostic by changing it to a “multiplex test with an added reverse primer.” The test had been unable to detect the Omicron variant of the disease.
You may also be interested in...
FDA Says Another COVID-19 Test Thrown Off By Omicron Variant
The US FDA has added the Linea COVID-19 Assay Kit to its list of diagnostics that could produce false-negative results due to the most recent coronavirus mutation.
Another COVID-19 Diagnostic Impacted By Omicron Variant
The Revogene SARS-CoV-2 test from Meridian Bioscience could give false-negative results because of the latest coronavirus variant. The good news is that the diagnostic hasn’t been distributed in the US, the FDA says.
COVID-19 Omicron Variant Could Cause False-Negative Results In Tide Labs Test, FDA Says
The US FDA said this week that the DTPM COVID-19 RT-PCR Test made by Tide Laboratories LLC could give erroneous readings because of the latest coronavirus variant.